{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:23:54Z","timestamp":1790411034202,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NIH","award":["1 U01 AI070443-01"],"award-info":[{"award-number":["1 U01 AI070443-01"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.vaccine.2011.07.054","type":"journal-article","created":{"date-parts":[[2011,8,2]],"date-time":"2011-08-02T04:51:31Z","timestamp":1312260691000},"page":"7456-7462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Novel formulations enhance the thermal stability of live-attenuated flavivirus vaccines"],"prefix":"10.1016","volume":"29","author":[{"given":"O\u2019Neil","family":"Wiggan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill A.","family":"Livengood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn J.","family":"Silengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Kinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge E.","family":"Osorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire Y.-H.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan T.","family":"Stinchcomb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.07.054_bib0005","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1017\/S002217240000053X","article-title":"The development of a stable smallpox vaccine","volume":"53","author":"Collier","year":"1955","journal-title":"J Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2011.07.054_bib0010","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/jps.10296","article-title":"Thermal stability of vaccines","volume":"92","author":"Brandau","year":"2003","journal-title":"J Pharm Sci"},{"issue":"7","key":"10.1016\/j.vaccine.2011.07.054_bib0015","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1128\/JVI.74.7.3020-3028.2000","article-title":"Chimeric dengue type 2 (vaccine strain PDK-53)\/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine","volume":"74","author":"Huang","year":"2000","journal-title":"J Virol"},{"issue":"21","key":"10.1016\/j.vaccine.2011.07.054_bib0020","doi-asserted-by":"crossref","first-page":"11436","DOI":"10.1128\/JVI.77.21.11436-11447.2003","article-title":"Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development","volume":"77","author":"Huang","year":"2003","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2011.07.054_bib0025","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1128\/JVI.79.12.7300-7310.2005","article-title":"Chimeric dengue 2 PDK-53\/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus","volume":"79","author":"Huang","year":"2005","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.07.054_bib0030","first-page":"189","article-title":"Immunization with a live attenuated dengue-2-virus candidate vaccine (16681-PDK 53): clinical, immunological and biological responses in adult volunteers","volume":"65","author":"Bhamarapravati","year":"1987","journal-title":"Bull World Health Organ"},{"issue":"23-24","key":"10.1016\/j.vaccine.2011.07.054_bib0035","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1016\/S0264-410X(01)00020-2","article-title":"Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers","volume":"19","author":"Kanesa-thasan","year":"2001","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2011.07.054_bib0040","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0264-410X(95)00167-Y","article-title":"Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in ten American volunteers","volume":"14","author":"Vaughn","year":"1996","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2011.07.054_bib0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/infdis\/170.1.27","article-title":"Dengue virus-specific memory T cell responses in human volunteers receiving a live attenuated dengue virus type 2 candidate vaccine","volume":"170","author":"Dharakul","year":"1994","journal-title":"J Infect Dis"},{"issue":"32","key":"10.1016\/j.vaccine.2011.07.054_bib0050","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1016\/S0264-410X(01)00236-5","article-title":"Induction of T lymphocyte responses to dengue virus by a candidate tetravalent live attenuated dengue virus vaccine","volume":"19","author":"Rothman","year":"2001","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2011.07.054_bib0055","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1006\/viro.1997.8500","article-title":"Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53","volume":"230","author":"Kinney","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2011.07.054_bib0060","first-page":"219","article-title":"Stability of yellow fever vaccine","volume":"87","author":"Monath","year":"1996","journal-title":"Dev Biol Stand"},{"issue":"4","key":"10.1016\/j.vaccine.2011.07.054_bib0065","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/biol.1998.0157","article-title":"Stability of 17D yellow fever virus vaccine using different stabilizers","volume":"26","author":"Adebayo","year":"1998","journal-title":"Biologicals"},{"issue":"9284","key":"10.1016\/j.vaccine.2011.07.054_bib0070","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0140-6736(01)05967-0","article-title":"Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study","volume":"358","author":"Bista","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.07.054_bib0075","first-page":"38","article-title":"Studies on the production of SA14-2 Japanese encephalitis live vaccine","volume":"6","author":"Wang","year":"1990","journal-title":"Chin J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2011.07.054_bib0080","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-1157(80)80005-9","article-title":"Stability on storage at various temperatures of live measles: mumps and rubella virus vaccines in new stabilizer","volume":"8","author":"McAleer","year":"1980","journal-title":"J Biol Stand"},{"issue":"1","key":"10.1016\/j.vaccine.2011.07.054_bib0085","first-page":"1","article-title":"Formulation: stability, and delivery of live attenuated vaccines for human use","volume":"16","author":"Burke","year":"1999","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"11","key":"10.1016\/j.vaccine.2011.07.054_bib0090","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/sj.gt.3301189","article-title":"A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle","volume":"7","author":"Lemieux","year":"2000","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2011.07.054_bib0095","first-page":"341","article-title":"Systematic development of a block copolymer adjuvant for trivalent influenza virus vaccine","volume":"92","author":"Todd","year":"1998","journal-title":"Dev Biol Stand"},{"issue":"3","key":"10.1016\/j.vaccine.2011.07.054_bib0100","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejpb.2005.06.006","article-title":"Delivery of a lentiviral vector in a Pluronic F127 gel to cells of the central nervous system","volume":"61","author":"Strappe","year":"2005","journal-title":"Eur J Pharm Biopharm"},{"issue":"11","key":"10.1016\/j.vaccine.2011.07.054_bib0105","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1021\/js980072c","article-title":"Design and development of adjuvant-active nonionic block copolymers","volume":"87","author":"Newman","year":"1998","journal-title":"J Pharm Sci"},{"issue":"8","key":"10.1016\/j.vaccine.2011.07.054_bib0110","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/BF02976716","article-title":"Fluorescence spectroscopy studies on micellization of poloxamer 407 solution","volume":"26","author":"Lee","year":"2003","journal-title":"Arch Pharm Res"},{"issue":"1","key":"10.1016\/j.vaccine.2011.07.054_bib0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/JVI.72.1.73-83.1998","article-title":"Phylogeny of the genus flavivirus","volume":"72","author":"Kuno","year":"1998","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11010991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11010991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:17:45Z","timestamp":1759400265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11010991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":23,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0264410X11010991"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.07.054","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.12663958.13914060","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel formulations enhance the thermal stability of live-attenuated flavivirus vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.07.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}